MMP-7 / MMP-9 in stable lung transplant recipients - a potential role in obliterative bronchiolitis Source: Eur Respir J 2003; 22: Suppl. 45, 202s Year: 2003
Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007
Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010
Bronchiolitis obliterans formation by epithelial-mesenchymal transition in lung transplant recipients Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010
Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients? Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
In vitro model to study the correlation between neutrophils and miR21 expression: a role in Bronchiolitis obliterans syndrome Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003
Towards a model of bronchiolitis obliterans syndrome in single lung transplanted mice Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010
Development of a novel model of obliterative bronchiolitis following orthotopic lung transplantation in the rat Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008
Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005